Carton (Image 01)
Vyxeos Injection, Powder, Lyophilized, For Suspension
Product Images NDC 68727-745
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vyxeos (NDC 68727-745). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Jazz Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Daunorubicin (Image 02)
Cytarabine (Image 03)
Kaplan-meier Curve (Image 04)
This is a survival graph showing the median survival rates and 95% confidence levels of patients treated with Vyxeos (a type of chemotherapy drug) versus those treated with the standard 7+3 chemotherapy regimen. The graph displays the percentage survival rates over time, with the x-axis representing the months from randomization and the y-axis showing the percentage of patients who survived. The Vyxeos group had a higher median survival rate of 9.56 months (95% CI: 6.60-11.86) compared to the 7+3 group, whose median survival rate was 5.95 months (95% CI: 4.99-7.75). The graph also shows the number of events and the number of patients at risk at each time point for each treatment group.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
